GUDCA treatment partially attenuated down-regulation in SERCA2 induced by HFD, mitigating Ca2+ depletion from the ER lumen and inhibition of ER stress, then alleviating metabolic diseases, which may be the mechanism throughout the present study. The gene discussed is ATP2A2; the disease is Other metabolic disease.